Takeda Pharmaceutical (TAK)

• Market cap: $43.2B
• 1 day: -3.31%
• 5 days: -9.14%
• 1 month: -4.06%
• 3 months: 0.73%
• 6 months: 1.18%
• Year to date: 3.55%
• 1 year: 4.65%
• 5 years: -26.87%
• 10 years: -17.55%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Employees: 49,281

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

4,520% more call options, than puts

Call options by funds: $22.9M | Put options by funds: $496K

7% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 94

5% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 42

0.26% less ownership

Funds ownership: 4.79% [Q3] → 4.53% (-0.26%) [Q4]

2% less funds holding

Funds holding: 298 [Q3] → 293 (-5) [Q4]

6% less capital invested

Capital invested by funds: $1.02B [Q3] → $954M (-$62.3M) [Q4]